Schroder Investment Management Group
MRNA icon

Schroder Investment Management Group’s Moderna MRNA Stock Holding History

Schroder Investment Management Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,484
Closed -$317K – 1235
2025
Q2 		$317K Sell
11,484
-18,652
-62% -$491K ﹤0.01% 1088
2025
Q1 		$938K Sell
30,136
-1,968
-6% -$69.8K ﹤0.01% 1000
2024
Q4 		$1.26M Sell
32,104
-103,486
-76% -$4.95M ﹤0.01% 982
2024
Q3 		$8.92M Buy
135,590
+102,686
+312% +$9.43M 0.01% 684
2024
Q2 		$3.91M Sell
32,904
-869
-3% -$110K ﹤0.01% 817
2024
Q1 		$3.6M Buy
33,773
+1,662
+5% +$168K ﹤0.01% 836
2023
Q4 		$3.19M Sell
32,111
-8,867
-22% -$746K ﹤0.01% 842
2023
Q3 		$4.23M Buy
40,978
+1,276
+3% +$142K 0.01% 780
2023
Q2 		$4.82M Buy
39,702
+5,134
+15% +$685K 0.01% 797
2023
Q1 		$5.31M Sell
34,568
-7,421
-18% -$1.22M 0.01% 775
2022
Q4 		$7.54M Buy
41,989
+1,041
+3% +$170K 0.01% 691
2022
Q3 		$4.84M Sell
40,948
-47,134
-54% -$7.15M 0.01% 774
2022
Q2 		$12.6M Sell
88,082
-86,865
-50% -$12.4M 0.02% 600
2022
Q1 		$30.6M Sell
174,947
-92,725
-35% -$15.6M 0.04% 392
2021
Q4 		$68M Buy
267,672
+79,034
+42% +$23.1M 0.09% 229
2021
Q3 		$72.6M Sell
188,638
-142,591
-43% -$52.6M 0.11% 194
2021
Q2 		$77.8M Buy
331,229
+45,166
+16% +$8.07M 0.1% 206
2021
Q1 		$37.5M Buy
286,063
+189,307
+196% +$27.4M 0.05% 356
2020
Q4 		$10.1M Buy
+96,756
New +$9.79M 0.01% 630
2020
Q3 		– Sell
-47,108
Closed -$3.02M – 1376
2020
Q2 		$3.02M Sell
47,108
-35,740
-43% -$1.96M 0.01% 752
2020
Q1 		$2.87M Buy
82,848
+2,782
+3% +$64K 0.01% 755
2019
Q4 		$1.57M Sell
80,066
-2,701
-3% -$47.9K ﹤0.01% 917
2019
Q3 		$1.32M Buy
82,767
+5,046
+6% +$74.5K ﹤0.01% 948
2019
Q2 		$1.14M Sell
77,721
-17,216
-18% -$370K ﹤0.01% 895
2019
Q1 		$1.93M Buy
94,937
+34,937
+58% +$648K ﹤0.01% 815
2018
Q4 		$916 Buy
+60,000
New +$986K ﹤0.01% 894

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Schroder Investment Management Group's MRNA Position: Q3 2025 in Review

Schroder Investment Management Group sold out of Moderna (MRNA) in Q3 2025, closing a stake of 11,484 shares — an estimated $317K sold.

Schroder Investment Management Group first reported a position in MRNA in Q4 2018 and held it in 26 quarters. The position peaked at $77.8M in Q2 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Schroder Investment Management Group reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 11,484 Moderna shares in Q3 2025, an estimated $317K.
  • Schroder Investment Management Group first reported a position in Moderna in Q4 2018 and held it in 26 quarters.
  • Schroder Investment Management Group's Moderna position peaked at $77.8M in Q2 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.